Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Baumert

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gastroenterologie Clinique Et Biologique|June 12, 2010
Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infectionS Pfeffer, T F Baumert
Hepatology (Baltimore, Md.)|January 1, 1996
Precore mutants revisitedT F Baumert, T J Liang
Minerva Gastroenterologica E Dietologica|March 10, 2005
Genetic variants of hepatitis B virus and their clinical relevanceT F Baumert, H Barth, H E Blum
Journal of Virology|July 11, 1998
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expressionT F Baumert, A Marrone, J Vergalla, et al.
Journal of Virology|April 29, 1998
Hepatitis C virus structural proteins assemble into viruslike particles in insect cellsT F Baumert, S Ito, D T Wong, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 2014
[Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]R Thimme, M Heim, T F Baumert, et al.
The Journal of Clinical Investigation|November 15, 1996
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replicationT F Baumert, S A Rogers, K Hasegawa, et al.
Deutsche Medizinische Wochenschrift (1946)|April 3, 2014
[Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]R Thimme, M Heim, T F Baumert, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in miceM Lechmann, K Murata, J Satoi, et al.
Gut|August 28, 2009
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replicationK Himmelsbach, D Sauter, T F Baumert, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gastroenterologie Clinique Et Biologique|June 12, 2010
Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infectionS Pfeffer, T F Baumert
Hepatology (Baltimore, Md.)|January 1, 1996
Precore mutants revisitedT F Baumert, T J Liang
Minerva Gastroenterologica E Dietologica|March 10, 2005
Genetic variants of hepatitis B virus and their clinical relevanceT F Baumert, H Barth, H E Blum
Journal of Virology|July 11, 1998
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expressionT F Baumert, A Marrone, J Vergalla, et al.
Journal of Virology|April 29, 1998
Hepatitis C virus structural proteins assemble into viruslike particles in insect cellsT F Baumert, S Ito, D T Wong, et al.
Deutsche Medizinische Wochenschrift (1946)|March 21, 2014
[Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]R Thimme, M Heim, T F Baumert, et al.
The Journal of Clinical Investigation|November 15, 1996
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replicationT F Baumert, S A Rogers, K Hasegawa, et al.
Deutsche Medizinische Wochenschrift (1946)|April 3, 2014
[Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]R Thimme, M Heim, T F Baumert, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in miceM Lechmann, K Murata, J Satoi, et al.
Gut|August 28, 2009
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replicationK Himmelsbach, D Sauter, T F Baumert, et al.
Pageof 2